Tumor digital twins uncover therapeutic strategies in triple-negative breast cancer.
Computer models accurately predict which treatments will work for aggressive breast cancers, offering a path toward personalized therapy selection.
Triple-negative breast cancer (TNBC) is an aggressive malignancy with limited therapeutic options and a high risk of relapse and mortality. The model accurately predicts treatment responses and identifies mutational and transcriptional biomarkers associated with clinical outcome.
What the study was
- Study design
- Randomized controlled trial
- Category
- Other
- Maturity
- Potentially Practice-Changing
- Journal
- Cell Rep Med
Why it surfaced
Randomized controlled trial; human evidence; PubMed abstract reviewed; conservative rubric score 8/10.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.